Clover Health Investments (CLOV)
(Delayed Data from NSDQ)
$1.10 USD
0.00 (0.00%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $1.09 -0.01 (-0.91%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CLOV 1.10 0.00(0.00%)
Will CLOV be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for CLOV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLOV
Clover Health Investments, Corp. (CLOV) Reports Q1 Loss, Tops Revenue Estimates
Enovis (ENOV) Q1 Earnings Match Estimates
CLOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
3 Medical Info Systems Stocks to Buy as Industry Rebounds
Clover Health Investments, Corp. (CLOV) Upgraded to Buy: Here's Why
Other News for CLOV
Peering Into Clover Health Investments's Recent Short Interest
The 'Undercovered' Dozen From June 1-6
Clover Health: New Business Model Is A Game Changer
Clover Health offering clinical decision tool to all MA payors and providers
What's Driving Alignment Healthcare Inc's Surprising 16% Stock Rally?